However, among patients with hepatocellular carcinoma (HCC), irisin circulating levels are associated with higher NAFLD incidence through an increase in the expression of key de-novo lipogenesis proteins such as SCD1 and SREBPF1. The gene discussed is FNDC5; the disease is metabolic dysfunction-associated steatotic liver disease.